News

In the News
More
Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy.
7 August 2019
Q&A with Pulmocide CEO Garth Rapeport – Why Pulmocide is developing targeted lung therapy. Read More
How to spot the hidden gem investment funds
29 June 2019
How to spot the hidden gem investment funds Read More
CardioFocus lands $55M in funding for product launches
28 May 2019
CardioFocus lands $55M in funding for product launches Read More
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
20 May 2019
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S. Read More
Press Releases
More
Rheostat Therapeutics Announces Rebrand to Caraway Therapeutics and New Kendall Square Office
10 October 2019
Rheostat Therapeutics Announces Rebrand to Caraway Therapeutics and New Kendall Square Office Read More
AVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis
8 October 2019
AVROBIO Announces First Patient Dosed in Phase 1/2 Trial of Gene Therapy for Cystinosis Read More
Endotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution
1 October 2019
Endotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution Read More
Misonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical
27 September 2019
Misonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical Read More
Press Contacts
Michael-Jon Romano
Sommerfield Communications
T: (212) 255-8386
Events
More

View all events